<DOC>
	<DOCNO>NCT01017354</DOCNO>
	<brief_summary>This project design optimize vitamin D status prefrail senior age 70+ living home prevent functional decline . We test 3 arm monthly vitamin D supplementation . Intermittent dose improve adherence simplify vitamin D supplementation .</brief_summary>
	<brief_title>Zurich Disability Prevention Trial</brief_title>
	<detailed_description>We propose double-blind , randomize control trial test effectiveness 1 . Active I ( n=70 ) : monthly high-dose vitamin D3 supplement dose ( 60'000 IU/month , equivalent 2000 IU daily ) , 2 . Active II ( n=70 ) : monthly standard vitamin D3 supplement dose combine 25 ( OH ) D ( 24'000 IU/month , equivalent 800 IU daily PLUS 300 mcg 25 ( OH ) D , equivalent 10 mcg per day ) 3 . Control ( n=70 ) : compare standard vitamin D3 supplement dose ( 24'000 IU/month , equivalent 800 IU daily ) All individual advise consume calcium natural food source daily dose 600-800 mg day , include milk product . Maximal intake supplemental calcium restrict 250 mg per day .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>Inclusion criterion : Age 70+ Fall last 12 month screen ( without fracture ) Living home ( communitydwelling ) Men woman Mobile without walk aid able use public transportation attend clinical visit trial centre Score least 27 screen Folstein Mini Mental test + normal clock test Patient understand study procedure , alternative treatment available risk involve study , voluntarily agree participate give write informed consent . Patient meet entry minimal requirement base routine clinical laboratory safety screen test Folstein mini mental status ( score 27+ require ) perform Screening Visit . Patient willing perform study test , attend require office visit , provide blood urine sample . Exclusion criterion : Serum calcium adjust albumin &gt; 2.6 nmol/l Pathologic fracture last year ( except fracture due osteoporosis ) Chemo therapy / Radiation due cancer last year Treatment effect bone metabolism ( e.g . bisphosphonate , PTH , calcitonin , chronic cortisone intake &gt; XYmg/day XY month/years ( except inhalation sporadic infiltration ) ) Oral vitamin D intake 800 IU per day Unwilling stop calcium supplementation vitamin D supplementation trial ( maximal calcium supplement intake 250mg/d ; additional vitamin D supplementation ) Severe visual hearing impairment Unwilling unable take study medication Diseases risk recurrent fall ( e.g . Parkinson 's disease/syndrome , Hemiplegia stroke , symptomatic stenosis spinal canal , polyneuropathy , epilepsy , recur vertigo , recur syncope ) BMI &gt; = 40 Estimated creatinine clearance &lt; 15 ml/min ( estimate Creatinine Clearance Cockcroft Gault ) Malabsorption syndrome ( celiac disease , inflammatory bowl disease ) Diseases may enhance serum calcium : sarcoidosis , lymphoma , primary hyperparathyroidism kidney stone last 10 year Abnormal index calcium metabolism , uncontrolled hypocalcemia . Patient heavily consume alcohol contain product define great ( &gt; ) 3 drink ( beer , wine , distilled spirit ) alcoholic beverage per day . Patient unlikely adhere study procedure , keep appointment , plan relocate study . Patients plan stay `` sunny '' location ( e.g . winter sun resort ) two month per year Medication effect 25hydroxyvitamin D level ( e.g . certain anticonvulsant ( e.g . Phenobarbital , Carbamazepin , Phenytoin ) ) M. Paget ( Ostitis deformans ) inflammatory arthritis ( e.g . rheumatoid arthritis , reiter syndrome , psoriasis arthritis )</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>function</keyword>
	<keyword>fall</keyword>
	<keyword>25-hydroxyvitamin D</keyword>
	<keyword>disability</keyword>
</DOC>